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INTRODUCTION
Gender-specific differences in the occurrence of social and emotional disorders are well documented. Autism spectrum disorder (ASD), which is characterized by impaired social communication and restrictive, repetitive behaviors, is severalfold more prevalent in males than females (Rubenstein et al., 2015) . In contrast, anxiety-related disorders such as posttraumatic stress disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder occur approximately twice as frequently in females than in males (Altemus et al., 2014) . Although recent studies in rodents (Yang et al., 2013; Lee et al., 2014; Kunwar et al., 2015; Scott et al., 2015) and humans (Wigton et al., 2015; Insel, 2016) have provided strong evidence that differences in hormonal balance and brain circuitry between males and females can contribute to complex behaviors, the specific mechanisms that are responsible for gender biases in the occurrence and treatment of social and emotional disorders are not understood.
Oxytocin (OXT) is a peptide hormone that has been shown to contribute to many aspects of social behavior (Insel, 2010; Neumann and Slattery, 2016; Aoki et al., 2015; Guastella and Hickie, 2016) . It is released in response to a variety of social cues and acts through OXT receptors (OXTRs) that are widely dispersed in the brain and periphery (Owen et al., 2013) . Studies of behaviors altered in response to systemic or local administration of OXT and analysis of behavioral phenotypes evident in knockout mice lacking Oxt or Oxtr have demonstrated definitively that this hormone system plays essential roles in maternal care, social cognition, and affiliative behaviors. Stressful and anxiogenic stimuli result in the release of OXT, which acts as a powerful modulator of anxiety-and stress-related behaviors. These studies have led to a great deal of interest in OXT as a potential treatment for human social disorders, resulting in a large number of clinical trials to assess its therapeutic efficacy. Although the results of these trials have been encouraging in the context of ASD and anxiety disorders, our understanding of the brain circuits engaged by endogenous or exogenously supplied OXT and their role in specific behaviors remains incomplete.
We have recently identified a specific class of OXTR interneurons (OxtrINs) in the mouse medial prefrontal cortex (mPFC) that express Oxtr and are activated in response to OXT (Nakajima et al., 2014) . Genetic and pharmacological studies of these neurons revealed that they modulate female social interactions with male mice during the sexually responsive, estrus phase of their cycle. Although the number of OxtrINs in the male mPFC is equivalent to that in the female mPFC, social behavior of male mice was not altered by the silencing of OxtrINs or blockade of OXT signaling in the mPFC. While it is possible that these neurons are dedicated to modulation of social behaviors in female mice, OXT administration can impact a wide range of behaviors in both males and females. Furthermore, human imaging studies have indicated that OXT elicits activity in cortical and subcortical sites in both sexes, although gender-specific differences in these responses have been noted (Bethlehem et al., 2013; MacDonald and Feifel, 2014) . It seems probable, therefore, that OxtrINs in the mPFC of male mice also modulate behavior in response to changing levels of OXT, but that gender-specific differences in physiology or circuitry result in sexually dimorphic behavioral outcomes.
Here, we report that optogenetic activation of OxtrINs in male mice has a strong anxiolytic effect and no impact on social interaction, whereas activation of these neurons in female mice results in increased sociality and no change in anxiety-related (D) Photostimulation (light on, 10 Hz) in Oxtr-Cre::ChR2 female mice in the three-chamber social interaction test significantly increased social preference for male mice compared to time epochs without photostimulation (light off). n = 9 mice per group. Two-way ANOVA, Bonferroni post-test. ***p < 0.001. (E) Photostimulation (light on, 10 Hz) in Oxtr-Cre::ChR2 male mice did not increase social preference for female mice compared to time epochs without photostimulation. n = 8 mice per group. Two-way ANOVA, Bonferroni post-test. n.s., p > 0.05. (F-I) Optogenetic stimulation of the mPFC in Oxtr-Cre::ChR2 increased open-arm time in the EPM (G) and center time on the OF (I) during the light-on phase in males but not in females (F and H) . (F and G) n = 16 mice per group, Wilcoxon signed-rank test; p = 0.78 in (F) , and p = 0.0017 in (G) . (H and I) n = 7 to 9, MannWhitney test; p > 0.9 in (H), and p = 0.0164 in (I). behaviors. Postsynaptic responses to activation of OxtrINs in cortical pyramidal cells are primarily inhibitory. Layer 2/3 neurons respond more robustly in male mice, whereas postsynaptic responses in layer 5 are enhanced in females. TRAP (translational ribosome affinity purification) translational profiling (Heiman et al., 2008) revealed that expression of the corticotropin-releasing-hormone (CHP)-binding protein (CRHBP) gene (Crhbp) (Van Den Eede et al., 2005) , an inhibitor of the stress hormone CRH (Laryea et al., 2012) , is specifically enriched in OxtrINs. Upon CRH application, induced activity of male, but not female, layer 2/3 pyramidal cells in mPFC slice recordings was potentiated. This response to CRH was blocked by optogenetic stimulation of OxtrINs and enhanced by bath application of a CRHBP antagonist. Infusion of OXT into the mPFC resulted in a significant decrease of anxiety-related behavior in male mice. This anxiolytic effect was blocked by co-infusion of a CRHBP antagonist. Furthermore, short-hairpin-RNA (shRNA)-mediated knockdown of Crhbp expression in OxtrINs of the mPFC resulted in increased anxiety-related behaviors only in male mice. Finally, CRH expression in female mice is strongly elevated. Taken together, these data identify a molecular mechanism regulating male-specific anxiety-related behaviors. They demonstrate that OXT acts through OxtrINs and CRHBP to moderate the anxiogenic effects of the stress hormone CRH in the mPFC. When taken together with our previous study of the role of OxtrINs in female sociosexual behavior, these results provide an important illustration of the concept that higher brain circuits regulating complex behaviors may be identical in males and females yet retain the ability to generate gender-specific behaviors based on differential sensitivity to sexually dimorphic hormones. They suggest that coordination of the local actions of OXT and CRH in the cerebral cortex by OxtrINs and CRHBP may be involved in the modulation of a wide variety of gender-specific cognitive and behavioral functions.
RESULTS

OxtrINs in the mPFC of Male Mice Modulate AnxietyRelated Behaviors
To investigate the function of OxtrINs in male mice, we performed two types of genetic manipulations. First, we used Oxtr-Cre mice (Nakajima et al., 2014) for optogenetic activation of OxtrINs ( Figures 1A-1I ). For this purpose, the mPFC of male and female Oxtr-Cre mice were stereotactically injected with a Cre-dependent AAV virus expressing channelrhodopsin (ChR2-H134R), and fiber-optic cannulas were implanted in the prelimbic cortex (Figures 1A-1C ; Figures S1A-S1D ). Behavioral responses during blue-light (BL) on and off periods were scored in the three-chamber social interaction test, the open field (OF) test, and the elevated plus maze (EPM). Optogenetic activation of OxtrINs in the mPFC of female mice promoted social preference toward male mice ( Figure 1D ), consistent with the suppression of sociosexual preference observed by silencing these same neurons (Nakajima et al., 2014) . However, male mice showed no significant changes in social interaction upon light activation of OxtrINs ( Figure 1E ). Given that the oxytocin system can also affect behavioral responses to stress (Neumann and Slattery, 2016) , we next examined whether OxtrINs can contribute to the regulation of anxiety-related behaviors in males.
Avoidance of the open arms of the EPM and decreased exploration time in the center of the OF are established behavioral tests that are used to assess anxiety-like behavior in rodents. In female mice, activation of OxtrINs by BL had no impact on the behavior of the animals in either of these assays ( Figures  1F and 1H ). However, optogenetic activation of OxtrINs in the mPFC of male mice resulted in more exploration of the open arms of the EPM ( Figure 1G ) and increased time in the center area of the OF arena ( Figure 1I ) compared to the light-off phase.
As expected, the strength of the anxiety phenotype in male mice correlated directly with the number of OxtrINs expressing ChR2 ( Figures S1A-S1C ). These data demonstrate that activation of OxtrINs in the mPFC results in the induction of distinct genderspecific behaviors. They confirm our previous studies demonstrating a role for OxtrINs in female sociosexual behavior (Nakajima et al., 2014) and establish a role for these same neurons in the modulation of anxiety-related behaviors in male mice. To determine whether the anxiolytic effect of OxtrINs in male mice requires OXT/OXTR signaling, as we have shown previously for sociosexual behavior in females (Nakajima et al., 2014) , we conducted a second set of experiments using Cre-expressing AAV viruses injected into mice carrying a conditional allele of the Oxtr gene (Oxtr flox/flox ) (Lee et al., 2008) . We bilaterally injected the mPFC of adult male and female Oxtr flox/flox mice with AAV-expressing Cre to delete the receptor (Oxtr f/f :Cre). As a control, we injected control Oxtr flox/flox mice with an AAV-expressing GFP (Oxtr f/f :GFP) that cannot result in deletion of Oxtr. As shown in Figures 1J and 1L , deletion of the Oxtr in female mice has no significant effect on performance in either the OF or EPM assays. However, in male mice, deletion of Oxtr resulted in a strong anxiogenic effect. Thus, male Oxtr f/f :Cre mice spent significantly less time in open arms of the EPM and in the center of the OF arena than did the control male Oxtr f/f :GFP mice ( Figures 1K and 1M ). There were no significant differences in anxiety levels between control males and females ( Figures 1F-1M) , and between females during estrus and diestrus ( Figure S1E ). There were also no major differences in total locomotor behavior as a consequence of optogenetic activation or Oxtr deletion, although a slight increase in female locomotion in the OF test was observed with Oxtr deletion (Figures S1F-S1I). We conclude that OXT action on OxtrINs in the mPFC regulates distinct, gender-specific behaviors.
Postsynaptic Responses to OxtrIN Activation Are Primarily Inhibitory
OxtrINs are regular spiking, GABAergic interneurons that increase their rate of firing in response to OXT (Nakajima et al., For (J) , n = 10 to 20 mice per group; for (K to M), n = 7 to 9 mice per group. Mann Whitney test; p = 0.64 in (J), and p = 0.04 in (K); p = 0.82 in (L) and p = 0.03 in (M). Data are represented as mean ± SEM. See also Figure S1 . 2014). To investigate the mechanism by which OxtrINs activation regulates local circuit activity, we performed whole-cell recordings of layer 2/3 and layer 5 pyramidal neurons in acute brain slices of the mPFC during photostimulation of ChR2-expressing OxtrINs (Figure 2 ). Brief light stimulation (470 nm) efficiently evoked action potentials in ChR2-mCherry expressing OxtrINs in slice preparations (Figures 2A-2C ). We observed no differences in the response of male and female OxtrINs to BL at different frequencies ( Figure 2C ). To measure postsynaptic responses to OxtrINs activation, light-evoked responses of layer 2/3 and layer 5 pyramidal neurons ( Figure 2D ) were recorded at 0-mV and À60-mV holding potentials, allowing independent detection of both GABA-and AMPA-receptor-mediated currents (Figures S2A and S2B) . OxtrINs synapse extensively with layer 2/3 and layer 5 pyramidal neurons in both genders. Thus, in males, 91.3% of layer 2/3 and 97% of layer 5 neurons responded to OxtrINs activation, whereas 95.2% of layer 2/3 and 95.6% of layer 5 pyramidal neurons responded in females ( Figure 2E) 2K ). These differences in IPSCs between males and females were observed at different BL intensities (Figures S2C and S2D) . Excitatory postsynaptic current (EPSC) amplitudes were also larger in females in layer 5 ( Figures 2J and 2K ). No differences in EPSC amplitudes in layer 2/3 (Figures 2G and 2H) were observed between male and female neurons. Thus, the electrophysiological evidence presented here establishes that there is broad connectivity between OxtrINs and pyramidal cells in the mPFC of both sexes and that the strength of inhibition in male and female neurons in the mPFC is both laminar and gender specific.
TRAP Reveals Cell-Specific Enrichment of CRHBP in OxtrINs Although the differences in postsynaptic inhibitory responses we observed between male and female neurons may explain the gender-specific anxiolytic effect of OXT, the response differences between genders suggested that additional factors might be involved. To gain insight into signaling pathways that are active in OxtrINs and to elucidate candidate mechanisms that might play a role in the anxiolytic effects of OxtrINs activation, we used TRAP to identify proteins actively synthesized in these cells in the mPFC. This was accomplished using Oxtr-Cre mice (Nakajima et al., 2014) crossed to EGFP-L10a reporter mice (Liu et al., 2014) (Figures S3A and S3B ), followed by TRAP profiling as described previously (Heiman et al., 2008) . Six replicate samples were collected from the mPFC of OxtrCre/EGFP-L10a mice, and the resulting RNA was sequenced from each sample. Normalized values from each of the six replicates and their averages were obtained for both the INPUT and immunoprecipitation (IP) samples (Table S1 ). These data provided us with a more comprehensive and quantitative list of highly translated mRNAs than that available from our previous microarray analyses and allowed us to confirm the reported (Nakajima et al., 2014) high expression and enrichment of somatostatin (Sst), glutamic acid decarboxylase 1 (Gad1), and Oxtr in OxtrINs. As shown in the scatterplot in Figure 3A , these markers are expressed at quite different levels, and each of them is significantly enriched in the OxtrINs IP data relative to the sample taken from the intact mPFC prior to IP (INPUT). To evaluate expressed genes as possible candidates for further analysis, we first removed genes whose mRNAs were present at low levels (base mean < 25.00) and then sorted for mRNAs that are highly enriched in the OxtrINs IP data (log 2 -fold change IP v INPUT). This resulted in the identification of a large number of known interneuron markers, and a variety of transcription factors, receptors, and signaling proteins that were not known previously to be enriched in OxtrINs (Table S1 ).
An intriguing candidate for further analysis, the corticotropin releasing hormone binding protein was among the most highly (C) Analyses of cell-specific translated mRNAs displayed using the Integrated Genomics Viewer (IGV 2.3). Positive control genes expressed in each cell type are indicated on the top row. Chrbp (last column, red arrow) is specifically expressed at very high levels in OxtrINs and at lower levels in a broad class of non-fastspiking interneurons that includes OxtrINs. See also Figure S3 and Table S1 .
enriched mRNAs in OxtrINs (log 2 -fold change = 4.64; Figure 3B ). CRHBP is a small, secreted glycoprotein that binds to CRH with equal or greater affinity than do the CRH receptors. The primary functional role of CRHBP is to bind and limit the bioavailability of CRH, thus diminishing the activity of CRH receptors (Westphal and Seasholtz, 2006) . CRH and CRH receptors have been shown to be critical regulators of stress and anxiety (Van Den Eede et al., 2005) , suggesting that production of CRHBP by OxtrINs may be important in the regulation of the male-specific anxiety-related behaviors ( Figure 1 ). To confirm that Crhbp expression is specific, two additional datasets were investigated. First, comparative expression of Crhbp in 20 cell types was evaluated using our internal database of cell-specific TRAP sequencing (TRAPseq) data. As shown in Figure 3C , Crhbp expression is very robust in OxtrINs relative to the other CNS cell types presented. The only other dataset in which Crhbp expression is evident is that collected from a broad population of Dlx1-expressing, non-fast-spiking cortical interneurons that includes OxtrINs (Nakajima et al., 2014) . Second, in situ hybridization (ISH) data from the Allen Brain Institute (http://www.brain-map. org/) was surveyed to determine whether the patterns of Crhbp and Crhr1 are consistent with our data ( Figures S3C and S3D ). Although specific cell-type localization is not possible to determine from the ISH data, the scattered pattern of Crhbp-positive cells in the mPFC is consistent with expression in interneurons. Given these data, we used fluorescence in situ hybridization (FISH) to confirm that OxtrINs express CRHBP ( Figure S3E ). The limited sensitivity of this approach did not allow accurate determination of the co-expression of Oxtr and Crhbp, although we reproducibly detected Oxtr in >50% of Crhbp positive cells. The significance of this result is enhanced both by the finding that the CRH receptor (Crhr1), which was present in the input cortical samples but not enriched in the IP ( Figure 3A ), is expressed specifically in layer 2/3 pyramidal cells ( Figure S3D ) and by our recent demonstration that layer 2/3 pyramidal cells in the mPFC can mediate stress-induced depressive behaviors (Shrestha et al., 2015) .
The Response of Layer 2/3 Pyramidal Neurons to CRH Is Enhanced in Male Mice and Blocked by Optogenetic Stimulation of OxtrINs
The CRH/CRHR1 system is considered fundamental for the regulation of stress and anxiety in both experimental animals and humans (Altemus et al., 2014; Bangasser and Kawasumi, 2015) . Genetic studies have established that loss of Crhr1 in glutamatergic cells in the cerebral cortex is anxiolytic (Refojo et al., 2011) and that CRH dysfunction can contribute to human anxiety-related-disorders (Weber et al., 2015; Smoller, 2016) . Although no data suggesting an interaction of the OXT/OXTR and CRH/CRHR1 systems in the cerebral cortex has been reported previously, the specific and high expression of Crhbp in OxtrINs suggested to us that the anxiogenic effects of CRH on layer 2/3 pyramidal cells might be modulated by release of CRHBP from OxtrINs and that differential sensitivity of this system may account for the male-specific anxiolytic effects of the activation of OxtrINs. As a first test of this hypothesis, electrophysiological responses of layer 2/3 pyramidal cells from female or male mPFC were assayed for their sensitivity to CRH and for the influence of the optogenetic activation of OxtrINs on these responses ( Figure 4 ). In each condition, the number of action potentials elicited (induced spikes) over an interval of 500 ms was measured, as the current was varied in steps of 50 pA from À50 pA to 400 pA ( Figure 4 ). Bath application of CRH (1 mM) to female slices resulted in a very small increase in activity at high current pulses ( Figures 4B and 4C ) that was insensitive to CRHR1 antagonists ( Figures 4B and 4C ). In contrast, in male slices, CRH increased the number of induced spikes at all currents tested ( Figures 4D and 4E ). This response was suppressed by co-application of CRHR1 antagonist ( Figures 4D and 4E ). These results demonstrate that male layer 2/3 pyramidal cells are more sensitive to CRH than are those of female mice and that this response is due to activation of the Crhr1 receptor. As predicted from the restricted expression of Crhr1 in layer 2/3 neurons, application of CRH to layer 5 pyramidal neurons did not alter induced spiking in recordings from either females or males (Figures S4A and S4B) . As shown in Figure 1 , optogenetic stimulation of OxtrINs in the mPFC of male mice is anxiolytic. To determine whether activation of male layer 2/3 pyramidal cells by CRH could be modulated by OxtrINs, we again injected AAV-ChR2-H134R into the mPFC of Oxtr-Cre mice. Brain slices were prepared 3 weeks after viral injection to test whether CRH activation of layer 2/3 pyramidal cells could be measured in the presence or absence of stimulation of OxtrINs by light. Optogenetic activation of OxtrINs in the slice preparation strongly diminished the activity of CRH on layer 2/3 male pyramidal cells at all current pulses (Figures 4F and 4G) . BL alone did not significantly reduce induced spiking in male and female layer 2/3 neurons ( Figures S4C and S4D) . These data directly demonstrate that OxtrINs play an important role in the male mPFC circuit by inhibiting the activation of layer 2/3 neurons in response to the stress hormone CRH.
OxtrINs Production of CRHBP Regulates Anxiety in Male, but Not Female, Mice CRHBP binds to CRH and inhibits its ability to activate its receptors (Van Den Eede et al., 2005) . Given the high and specific expression of Chrbp in OxtrINs (Figures 3 and S3 ), the robust potentiation of induced firing in pyramidal neurons of male mice by bath application of CRH, and the ability of optogenetic stimulation of OxtrINs to block the effects of CRH (Figure 4 ), we hypothesized that CRHBP released by OxtrINs binds to CRH and inhibits the stress-inducing effects of CRH that are elicited by its binding to CRHR1 receptors in layer 2/3 pyramidal cells. To test this hypothesis, we performed electrophysiological recordings with an antagonist to CRHBP to determine whether ambient levels of CRHBP in the slice preparations influence the activity of layer 2/3 pyramidal cells. Application of a CRHBP antagonist augmented the number of induced spikes at increasing current-clamp amplitudes (Figures 5A and 5B, blue) , indicating that CRHBP is present in the slice preparations and that it contributes to the observed activity of layer 2/3 pyramidal cells. Moreover, the addition of exogenous CRH (Figures 5A and 5B, green) further potentiated the effect of the CRHBP antagonist on induced activity. These data demonstrate that the balance of CRH and CRHBP is important for the regulation of local circuit activity in the mPFC and that a major role for CRHBP is to limit the actions of CRH at CRHR1 receptors in layer 2/3 pyramidal cells.
The simplest interpretation of the data we have presented thus far is that production of CRHBP in response to OXT activation of OxtrINs inhibits the anxiogenic effects of CRH, thus resulting in decreased anxiety-related behaviors. To assess this possibility in vivo and determine whether competition between CRH and CRHBP accounts for the anxiety phenotype in males, we designed lentiviral constructs to express shRNAs for the conditional knockdown of Crhbp in Cre-positive OxtrINs (LV-Crhbp shRNA and LV-scramble shRNA; Figure S5 ) (Ventura et al., 2004) . Cre-dependent expression of the shRNA was monitored by western blot analyses of CHRBP in transfected cells (Figures S5C and S5D) and by loss of EGFP upon excision of the loxPflanked cytomegalovirus (CMV)-EGFP cassette preceding the shRNA cassette ( Figure S5B ). Cre-dependent shRNA expression reduced the expression of CRHBP by 67% ( Figures S5C  and S5D ). Given the strong inhibition observed in the in vitro studies, we next tested the effect of the shRNA in vivo. Accordingly, Oxtr-Cre mice were injected bilaterally in the mPFC with LV-Crhbp shRNA and LV-scramble shRNA and tested in the EPM and OF. Anxiety-like behaviors were not affected by shRNA-mediated knockdown of Chrbp in female mice ( Figures  5C-5E ). However, males expressing the Crhbp shRNA spent less time in the open arms and entered the open arms and the center of the OF less frequently than did mice expressing the control scrambled shRNA (Figures 5F-5H ). These results clearly establish that Crhbp expression is essential for regulation of anxiety-related behaviors in male, but not female, mice. Furthermore, in spite of the critical role of OxtrINs in the regulation of social behavior and the expression of Crhbp in these neurons, knockdown of Crhbp in the mPFC of female mice had no impact on female sociosexual behavior ( Figure 5I ) or total locomotor behavior in male or female mice (Figures S5E and S5F) . It is apparent, therefore, that CRHBP produced by OxtrINs acts as a key molecular modulator for anxiety-related behaviors in male, but not female, mice.
While the CRHBP knockdown data demonstrate that CRHBP production by OxtrINs is an essential component of the pathway regulating male anxiety, it remained possible that CRHBP acts chronically to establish sensitivity to CRH rather than to dynamically regulate its function. To address this possibility, OXT was 
(legend continued on next page)
infused into the mPFC of male and female mice in the presence or absence of the CRHBP antagonist. As shown in Figure 5K , administration of OXT results in a strong, acute anxiolytic effect in male mice that is blocked by the CRHBP antagonist. No change in anxiety-related behavior was evident in female mice in response to OXT. These data prove that OXT can act in the PFC to dynamically regulate anxiety in male mice and that CRHBP acts downstream of OXT to mediate this anxiolytic effect.
CRH Expression Is Elevated in Female Mice
The male-specific anxiolytic effects of OxtrINs activation and its dependence on CRHBP could be the result of gender-specific differences in the expression or activity of any of the components of this system. To explore this issue, we first measured the expression of Oxtr, Crhbp, Crhr1, and Xist in the mPFC ( Figures  6A and 6B ). Since Oxtr and Crhbp are both expressed in OxtrINs, we quantitated their expression in TRAPseq data from replicate samples of male and female IPs ( Figure 6A ; Table S2 ). Crhr1 is not expressed in OxtrINs but in nearby cortical neurons and, thus, was measured in the INPUT samples ( Figure 6A ; Table  S1 ). Crhr2 was not expressed at significant levels in the mPFC. Xist (X-inactive specific transcript) was measured as an internal control for gender-specific expression in the INPUT of TRAP samples ( Figure 6A ; Table S1 ) because it is a non-coding RNA. No significant difference in the expression of Oxtr, Crhbp, or Crhr1 between male and female animals was observed (Figure 6A) . RT-PCR experiments were performed ( Figure 6B ) to confirm the TRAP results, revealing no significant changes in the expression of Oxtr, Crhbp, or Crhr1 in the mPFC of males and females. It is interesting to note that, in addition to the expected changes in expression of genes located on the X and Y chromosomes, a number of autosomal genes whose expression differs between genders are evident in these data (Table  S2) . While the magnitudes of these expression changes are small, and none appear to be directly relevant to the OXT or CRH pathways, future studies of these genes may yield additional insights into gender-specific functions of the mPFC. Next, we turned our attention to CRH. Two facts support the hypothesis that differences in the levels of CRH between males and females might account for the male-specific results presented thus far. First, the electrophysiological data we have presented in Figures 4 and 5 strongly support a model in which the balance of CRH and CRHBP determines the impact of this pathway on layer 2/3 pyramidal cell activity. Second, Crh expression is elevated in the female rat CNS (Iwasaki-Sekino et al., 2009) . Thus, Crh expression was measured in the paraventricular nucleus (PVN) of the hypothalamus (PVH) by RT-PCR. As shown in Figures 6C and 6D , the level of Crh present in the PVH of female mice is strongly elevated. These data both confirm previous studies cited earlier and suggest that the high level of CRH present in female mice may account for female insensitivity to OxtrINs expression of Crhbp.
A Model to Illustrate the Sexually Dimorphic Role of OxtrINs in the mPFC A model to illustrate the pathways involved in OxtrINs modulation of gender-specific social and emotional behaviors is presented in Figure 7 . The concept is simple: the PFC is tuned to respond to the changing levels of OXT and CRH that occur in a variety of social and stressful situations. In both genders, OXT stimulation of OxtrINs results in release of the fast-acting neurotransmitter GABA and the neuromodulator CRHBP. In female mice, the elevated levels of circulating CRH render the inhibitory action of CRHBP ineffective. Consequently, the dominant arm of the pathway in females (Figure 7 , orange arrow) is GABAergic modulation of layer 5 pyramidal cells. These cells respond more robustly to GABA in the female mPFC, and we believe that it is this pathway that is responsible for the modulation of social behavior. In male mice, due to limiting amounts of CRH in the mPFC, the critical OxtrINs modulatory event (Figure 7 , green panel) is the release of CRHBP, which intercepts CRH and inhibits its activation of layer 2/3 pyramidal cells expressing the CRHR1 receptor, thus producing an anxiolytic effect. Although GABA may augment the actions of CRHBP in this arm of the circuit, CRHBP is absolutely required. The relative activities of these two pathways-and, thus, the behavioral output of the circuit-depends on three factors: the balance of CRHBP released from OxtrINs versus the circulating levels of CRH, the fine tuning of postsynaptic responses to GABA in layer 5 and layer 2/3, and the actions of the two sexually dimorphic hormones OXT and CRH.
DISCUSSION
Differences in social and emotional behaviors between males and females are common. We have recently identified OxtrINs as a class of mPFC interneurons that respond to OXT and modulate sociosexual behavior in female, but not male, mice (Nakajima et al., 2014) . Here, we report that these same neurons in male, but not female, mice regulate anxiety-related behaviors. This role for OxtrINs is also dependent on OXT. It is due to production of CRHBP by OxtrINs, which suppresses the anxiogenic effects of CRH on postsynaptic layer 2/3 pyramidal cells. Although the number of Oxtr interneurons and the expression of Oxtr, Crhbp, and Crhr1 in the mPFC do not differ between (I and J) Oxtr-Cre female (I) and male (J) mice injected with Chrbp shRNA lentivirus showed no significant differences in the three-chamber social interaction test relative to Oxtr-Cre mice injected with shRNA scramble control. n = 5 to 9 mice per group; two-way ANOVA, Bonferroni's multiple comparison test. n.s., p > 0.05. (K) mPFC cannulated male mice were tested in the EPM after infusion of saline (light green), OXT (medium green), and OXT together with a CRHBP antagonist (dark green). Time in the open arms was significantly increased in male mice infused with OXT, and the anxiolytic effect of OXT was blocked by co-infusion with the CRHBP antagonist . n = 7 to 13 mice for each condition, one-way ANOVA, Bonferroni's multiple comparison test. *p < 0.05. Data are presented as mean ± SEM. See also Figure S5 . males and females, the expression of Crh in the hypothalamus of female mice is strongly elevated. Thus, our results demonstrate that the sexually bivalent roles of mPFC OxtrINs in social and emotional behaviors arise from gender-specific impacts on local circuitry that depend on distinct molecular pathways that confer sensitivity to sexually dimorphic hormones. They suggest that modulation of additional complex gender-specific social, emotional, and cognitive functions may rest upon the coordination of OXT and CRH actions by CRHBP expression in OxtrINs or other cellular and molecular mechanisms that are fine-tuned to modulate local, higher order circuitry in response to remote sexually dimorphic cues.
Sexually Dimorphic Neural Circuits
Differences in male and female behaviors in mammals ultimately derive from the effects of gonadal hormones (estradiol, progesterone, and testosterone) on the developing and adult nervous system (Pfaff and McEwen, 1983) . While the consequences of these hormones on brain development and function must be many and varied, recent studies focusing on their impact on hypothalamic circuits have advanced substantially our knowledge of cell types controlling sexually dimorphic behaviors. For instance, ablation of progesterone-receptor (PR)-expressing neurons in the ventromedial hypothalamus (VMH) results in deficits in mating behavior in both sexes yet reduces aggression in only males (Yang et al., 2013) . PR-expressing neurons differ in number, distribution, and connectivity in the VMH of males and females, suggesting that the gender-specific behavioral outcomes reflect the anatomical differences in PR-expressing neurons between sexes (Yang et al., 2013) . On the other hand, optogenetic activation of estrogen-receptor (ESR1)-expressing neurons in the VMH resulted in sexual approach behaviors in both males and females and stimulated attack behavior in males only (Lee et al., 2014; Kunwar et al., 2015) . In this case, ESR1-expressing cells are also sexually dimorphic, but attack behavior could be elicited simply by increasing photostimulation in male mice. It is clear from these studies that gender-specific behaviors reflect sexually dimorphic features of VMH neuronal populations in this hypothalamic circuitry. This is also the case in the anteroventral periventricular (APVP) hypothalamic nucleus, where a sexually dimorphic population of tyrosinehydroxylase (TH)-expressing neurons modulates parental care and oxytocin secretion specifically in females, while in males, TH-positive neurons in the APVP regulate inter-male aggression (Scott et al., 2015) . These studies provide potent and precise examples of the importance of sexually dimorphic cells and circuits in the hypothalamus for the regulation of gender-specific sexual and aggressive behaviors in mammals. They suggest that the identification and analysis of other sexually dimorphic modules will be a productive avenue for investigation of other sex-specific behavioral biases (Yang and Shah, 2014) .
Our studies of OxtrINs in the mPFC provide a different paradigm for the generation of gender-specific complex behaviors. In this case, the critical cell type is not sexually dimorphic: the number of OxtrINs does not vary between males and females in the mPFC (Nakajima et al., 2014) , and no gender-specific differences in expression of the key signaling proteins that regulate female social behavior or male anxiety are evident (Figure 6 ). However, OxtrINs produce two mechanistically distinct modulatory substances, GABA and CRHBP, which act on local circuits in the mPFC to regulate behavior differentially. They do so because their function requires the sexually dimorphic hypothalamic hormones OXT and CRH and because of the restricted expression of CRHR1 in superficial layers of the mPFC. Consequently, the high levels of OXT and CRH produced in females result predominantly in GABAergic control of postsynaptic cells by OxtrINs and modulation of social behavior. In males, the reduced production of CRH allows CRHBP released from OxtrINs to block activation of CRHR1 in layer 2/3 pyramidal cells, thus modulating anxiety-related behaviors. In this case, therefore, sexually dimorphic modules in the hypothalamus work remotely to regulate sexually bivalent behaviors through a uniform higher order circuit in the mPFC.
OXT, CRH, CRHBP, Stress, and Anxiety OXT is considered a ''social'' hormone because of the extensive literature documenting its ability to impact a variety of different social behaviors in many species and because its production is dynamically regulated in response to changing social situations (Insel, 2010; Neumann and Slattery, 2016; Guastella and Hickie, 2016) . OXT is produced in the hypothalamus and acts through the OXTR in many brain regions. Progress on circuits responsible for its role in social behaviors has been substantial: in the nucleus accumbens, it acts together with serotonin (5-HT) to modulate social reward through regulation of synaptic properties of both Drd1 and Drd2 expressing medium spiny neurons (Dö len et al., 2013) ; in the auditory cortex, OXT increases the salience of infant distress calls to stimulate maternal behavior in experienced, but not virgin, females (Marlin et al., 2015) ; and in the mPFC, OXT modulates the social approach toward male mice during estrus (Nakajima et al., 2014) . A second major role for OXT is the regulation of anxiety and stress (Neumann and Slattery, 2016) . OXT is produced in response to stress, and its abilities to modulate stress and anxiety have been demonstrated both pharmacologically and genetically. Although it is quite clear that responses to OXT administration in humans can vary between genders (Donaldson and Young, 2008) , little is known regarding higher order circuits that regu- late the anxiolytic effects of OXT or its differential effects in men and women.
The main system regulating physiological responses to stress is the hypothalamic-pituitary-adrenal (HPA) axis. CRH plays a fundamental role in stress because its production in the PVN stimulates the HPA axis, resulting in myriad peripheral physiological responses. The receptors for CRH (CRHR1 and CRHR2) are expressed in distinct patterns in the periphery and the brain (Laryea et al., 2012) . CRHR1, which has been strongly implicated in stress vulnerability (Labermaier et al., 2014) , is highly expressed in layer 2/3 pyramidal cells of the cerebral cortex (http://www.brain-map.org/; Figure S3D ). These cells are particularly vulnerable to stress, which typically induces alterations in their morphology and synaptic function. Layer 2/3 pyramidal cells in the mPFC also express the Wolfram syndrome gene, and it has been demonstrated recently that they are required to modulate stress-induced depressive behaviors (Shrestha et al., 2015) .
Although the central targets for OXT and CRH are largely distinct, stress and social behaviors are complex and intertwined (Sandi and Haller, 2015) . In general, stress results in decreased social motivation, reduced social interaction, and increased antisocial behavior. While the influence of social interactions on stress responses is less studied, recent evidence strongly supports the concept that ''social buffering'' can protect against a variety of stress related behaviors (Beery and Kaufer, 2015) . Administration of OXT in animal models promotes behavioral resilience to stress, and in humans, it both stimulates social behavior and decreases anxiety. Despite the roles of both OXT and CRH in the regulation of stress and anxiety, and the comorbidity of social and emotional disorders in humans, it has remained unclear how these systems are modulated in higher brains areas to control behavior.
The data we have presented here provides important mechanistic insights into the central coordination of social and anxiety-related behaviors. First, the observation that optogenetic activation of sexually monomorphic OxtrINs in the mPFC results in bivalent, gender-specific behaviors identifies these neurons as a critical node in social brain circuitry. Second, the discovery that this class of interneurons expresses CRHBP when activated, thus blocking the anxiogenic effects of CRH on layer 2/3 pyramidal cells in the cortex, provides a direct molecular mechanism through which OXT can both promote social behaviors and alleviate stress and anxiety. Third, the facts that OXT and CRH are circulating hormones whose actions are coordinated by OxtrINs in the mPFC and that the receptors for OXT and CRH are expressed in many brain regions suggest that CRHBP production in response to OXT may coordinate the actions of these hormones in other brain regions to modulate additional social and emotional behaviors. It will be of particular interest, for example, to determine whether OxtrINs production of CRHBP in the auditory cortex is involved in suppression of pup retrieval behavioral responses in virgin female or male mice (Marlin et al., 2015) and whether expression of CRHBP in the shell of the nucleus accumbens (http://mouse. brain-map.org) is involved in the modulation of social reward by OXT and serotonin (Dö len et al., 2013) . Finally, the model we have presented allows for graded control of behavior. Thus, the balance between the prosocial and anxiolytic effects of OXT will depend ultimately on the vast variety of circumstances that are known to alter the levels of OXT and CRH in the brain.
The mPFC, OxtrINs, Gender, and Therapy OXT is now being investigated intensively as a treatment for social/emotional disorders, including ASDs (Guastella and Hickie, 2016) , social anxiety disorders (Neumann and Slattery, 2016) , and schizophrenia (Insel, 2010; MacDonald and Feifel, 2014) . In the Cntnap2 mouse model of ASD, both exogenous and evoked OXT can restore normal social behaviors (Peñ agarikano et al., 2015) . Given the prominent role of OXT in female reproductive biology and behavior, gender is recognized as a critically important factor in studies of its therapeutic effects and development of improved treatments (Insel, 2016) . The sexually dimorphic role we have demonstrated for OxtrINs in the mPFC, the mechanistic relationship between OXT and CRH that we have discovered, and the arrangement of OxtrINs and Crhr1 pyramidal cells suggest that both gender and environment will be critically important for understanding the therapeutic efficacy of OXT. Thus, the mechanism we have described in the mPFC is sensitive to the levels of both hormones, which vary independently as a consequence of gender, social situation, and stress. Since it is capable of generating a graded response to the levels of OXT and CRH, the behavioral outcome of this system will be complex and dependent on all of the factors influencing OXT and CRH levels in vivo. Consequently, we expect that OXT therapy will be strongly dependent on the effective dose reaching the mPFC, the degree of target engagement, and the relative contributions of the mPFC and other sites to the overall clinical outcome. We speculate that, in some settings, it may be beneficial to reduce the impacts of gender and environment by artificially titrating these pathways through combined therapy using OXTR agonists and CRHR1 antagonists.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
All procedures involving mice were approved by The Rockefeller University Institutional Animal Care and Use Committee (IACUC) and were in accordance with the National Institutes of Health guidelines. All mouse lines were bred to C57BL/6J (Jackson Stock #000664) for more than 7 generations. Male and female transgenic mice were bred in our facility and were 2-3 months of age, 22-26 g weight, at the beginning of each experiment. Oxtr-Cre ON82 transgenic mice previously generated (Nakajima et al., 2014) were crossed with knockin Rosa-flox-EGFP-L10a line (Liu et al., 2014) to generate the Oxtr-EGFP-L10a (TRAP) line. The conditional knockout mouse line of the oxytocin receptor (Oxtr-CKO) was donated by Dr. W. Scott Young III (Lee et al., 2008) . Mice were housed in a specific-pathogen free facility, in groups of four to five per cage under a 12-h light-dark cycle with food and water ad libitum. Littermates of the same sex were randomly assigned to different experimental groups. 
METHOD DETAILS
Behavioral Testing Sociosexual Behavior Sociosexual behavior was measured using the three-chamber social interaction chamber as previously described (Nakajima et al., 2014) . The apparatus is comprised of a rectangular, three chamber box. Each dividing wall has an open middle section, which allows free access to each chamber. Two identical wire cups are placed in each side chamber. Animal behaviors were scored three weeks after surgery and virus injection. Prior to behavioral testing, the test mouse was moved to a holder cage and the fiber optic cannula was connected to the fiberoptic patchcord. The sociosexual behavior test comprised two parts: a habituation session and 2 trial sessions. During the habituation session, two empty wire cups were placed in the left and right chambers. The test mouse was placed in the middle chamber and allowed to explore all three chambers of the apparatus for 10 min. The doors to the side chambers were closed, the test mouse was placed in the middle chamber, and a stranger mouse of the opposite sex and a novel lego were placed inside the left or right wire cups randomly. Doors between chambers were opened to allow the test mouse to explore the three chambers freely. For mice expressing Cre dependent ChR2-mCherry in the mPFC, the test mouse was allowed to explore and interact with the stranger animal or lego for 2 trial sessions and each trial lasted for 10min. Blue light was generated by 473nm laser at 1mW and driven at 10Hz to activate OxtrINs cell bodies. During each social interaction session, the light was off during the first 3 min and on during the following 3 min. Two trial sessions were performed and the total duration that the mice spent in sniffing the stranger mouse or lego during the 6 min light-off and 6 min light-on phases were analyzed. Sociosexual behavior tests in Oxtr-cKO and Crhbp shRNAinjected mice did not require optogenetic stimulation and comprised a habituation period and one trial session during which the test mouse was allowed to explore the chamber for 10 min and sniffing behaviors were scored during this period. Mouse behavior was videotracked (Noldus system) and sniffing time was manually scored with Nodules software. The experimenter was blind to the type of virus injected besides for AAV-DIO-ChR2 injected mice. No mice were excluded from the Sociosexual Behavior.
Elevated Plus Maze
The apparatus consisted of two open arms, two closed arms and a center zone. Light intensity on the center zone and two open arms was always measured by light meters at the beginning of each experimental day. For EPM tests combined with optogenetics (OxtrChR2 mice), the light intensity in the center zone of EPM was adjusted to 130 Lux. Prior to behavioral testing, the test mouse was moved to a holder cage and the fiber optic cannula was connected to the fiber optic patchcord. The test mouse was placed in the center zone of the EPM facing an open arm. The EPM trials consisted of 5 min light off and 5 min light on phases. For EPM tests in Oxtr-cKO and Crhbp shRNA experimental groups, which did not require optogenetics, light intensity in the center zone was maintained at 60 lux. Mice were allowed to move freely in the maze for 5 min. The distance moved, the time spent in each arm and the number of entries into each arm were automatically analyzed by Noldus software. The experimenter was blind to the type of virus injected besides for AAV-DIO-ChR2 injected mice. Animals falling off from open arms were excluded from analyses.
Open Field Test
Animal behavior in the open field was automatically measured by fusion software. The test mice were introduced into a corner of the open arena (50*50*30cm) and allowed to explore for 30 min. Parameters including total distanced traveled and time spent in the center of the open field were measured by the Fusion tracking software. For OPT tests in Crhbp shRNA experimental groups, the number of entries into the center zone during the first 5 min were automatically analyzed by the Fusion tracking software. The experimenter was blind to the type of virus injected besides for AAV-DIO-ChR2 injected mice. Mice injected with AAV-DIO-ChR2 virus were randomly divided into light on and light off groups. No mice were excluded from the Open field test.
Brain Slice Preparation
Adult mice (2-3 months) were anesthetized with Ketamine/Xylazine and perfused with 20 ml chilled dissection buffer (25.0 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM KCl, 0.5 mM CaCl2, 7.0 mM MgCl2, 25.0 mM glucose, 110.0 mM choline chloride, 11.6 mM ascorbic acid and 3.1 mM pyruvic acid, gassed with 95% O2 and 5% CO2). Coronal mPFC slices of 300mm thickness were sectioned in chilled dissection buffer with a VT1000s vibratome (Leica). Slices were incubated in oxygenated artificial cerebrospinal fluid (ACSF; 118 mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 10 mM glucose, 1.3 mM MgCl2 and 2.5 mM CaCl2, gassed with 95% O2 and 5% CO2), let recover for 90 min at 32 C and transferred to room temperature until electrophysiological recordings.
Electrophysiological Recordings
Slices were continuously perfused with ACSF in the recording chamber and Patch-clamp experiments were performed at 32 C using a temperature control system. Signals were amplified using EPC10-2 amplifier (HEKA Elektronik, Lambrecht, Germany). Slices were visualized under a Zeiss microscope station equipped with camera. The pipette resistance was in the range of 4-6 MU. For voltage clamp recordings, the intracellular solution contained (in mM): 115 CsMeSO3, 20 CsCl, 10 HEPES, 2.5 MgCl2, 4 Na2-ATP, 0.4 Na-GTP, 10 Na-phosphocreatine, and 0.6 EGTA. For current-clamp recordings, the composition of the intracellular solution was (in mM): 130 K-Gluconate, 5 KCl, 10 HEPES, 2.5 MgCl2. 4 Na2ATP, 0.4 Na3GTP, 10 Na-phosphocretine, 0.6 EGTA. Current clamp recordings were filtered at 2.5kHz and sampled at 5kHz. Voltage-clamp recordings were filtered at 2.5kHz and sampled at 10kHz using Pathmaster program (HEKA Elektronik). Data were analyzed by Fitmaster (HEKA Elektronik). To measure light-evoked postsynaptic currents, 5 ms 470nm light pulses were delivered to the mPFC via an optic fiber attached to a laser. Layer 2/3 pyramidal cells were clamped at 0mV and À60mV. Ten sweeps were taken at each potential. To confirm the excitatory or inhibitory currents evoked by light, picrotoxin (100mM), D-APV (100mM) and CNQX (20mM) were added during the recordings. Peak amplitude was calculated by subtracting the baseline. Synaptic latency was determined as the duration from current onset time to peak time. To examine the effect of CRH (1mM, BACHEM), CRHR1 antagonist (NBI 27914 hydrochloride, 5uM, Tocris), and the CRHBP antagonist (CRF 6-33, 1mM, BACHEM) on excitability of layer 2/3 pyramidal neurons, we injected sequential currents from À50pA to 400pA in a 50pA step during 500ms. Current was injected every 60 s in current clamp. To measure the effect of light on excitability, continuous blue light was delivered at the same time of current injection. Littermates were randomly used to prepare brain slices treated with different drugs. Two to four independent datasets were collected.
Stereotactic Surgeries
Adult male and female mice (2-3 month old) were anesthetized with a mix of ketamine (100mg/ml) and xylazine (1mg/ml) by intraperitoneal injection. Oxtr-Cre mice received unilateral virus infusion of AAV5-DIO-hChR2(H134R)-mcherry in the mPFC using the coordinates: (A-P: 1.84 to 1.50 mm; M-L: 0.28 mm; D-V: 2.2 from dura). We injected 0.25 ml of AAV virus per site. Fiber optic cannulae were implanted after virus injection using the coordinates: (A-P: 1.60 mm; M-L: 0.28 mm; D-V 1.9 mm). Oxtr f/f mice received AAV8-cre expressing virus bilaterally in the mPFC for conditional deletion of oxtr. Lentivirus expressing Crhbp shRNA (1ml virus per site) were bilaterally injected into Oxtr-cre mice to silence Crhbp in OxtrINs. The coordinates were the same as above. Behavioral experiments were performed 3 weeks after the surgery.
For infusion experiments, double guide cannulae (C235GS-5-0.5/SP, Plastic One) were implanted following bilateral craniotomy and attached to the skull using dental cement (S380, C&B-Metabond). Behavioral experiments were performed 3 weeks after the surgery. Twenty five minutes before the EPM behavioral test, either saline, or OXT (1mg/ml H-2510, BACHEM) or OXT and CRHBP antagonist (CRF 6-33; 50mg/ml, BACHEM) were infused in a volume of 1 ml through the internal cannula inserted in the guide cannula.
TRAP
Three male and three female Oxtr-EGFP-L10a mice were used for independent TRAP replicates. The TRAP procedure was performed as described previously (Mellé n et al., 2012) . In brief, medial prefrontal cortices were dissected from individual mice. Tissue was immediately homogenized with a motor-driven Teflon glass homogenizer. Polyribosomes were immunoprecipitated by monoclonal anti-EGFP antibodies (custom made, a mix of 19C8 and 19F7)-coated protein L magnetic beads. RNAs from polyribosomes were extracted and further purified with an Rneasy Plus Micro Kit. RNA quantity and quality were determined with an Agilent 2100 Bioanalyzer. cDNA was synthesized from 5ng of mRNA from IP and input samples and further amplified by Oviation RNA-seq Kit. cDNA fragments of 200 bp were end-repaired and ligated with adapters for HiSeq 2000 (Ilumina Inc., San Diego, CA, USA) technology using TruSeq Nano DNA Sample kit (Illumina). Quality of libraries was assessed using HT DNA High Sensitivity Chip (Agilent) for 2100 Bioanalyzer. RNA-seq reads were aligned to the UCSC mm10 reference genome using STAR (version 2.3.0e_r291). Aligned reads were quantified by htseq-count module, part of the 'HTSeq' framework (version 0.6.0). Differentially expressed genes were identified by performing a negative binomial test using DESeq2 (R-package version 1.4.5) with default settings. Significant p values were corrected to control the false discovery rate of multiple testing at 0.05 threshold.
FISH FISH was performed as described previously (Nakajima et al., 2014) . 12-mm brain sections were collected on slides. Crhbp probe template was generated by PCR using gene-specific primers (F: CCCTCTCCTGCTCTTCAGTG, R: ATGGCTCCAGCTGACGATAC; from Crhbp cDNA plasmid). The PCR product was used to make Digoxigenin (DIG) labeled RNA probes using a T7-based in vitro transcription kit (Roche). Sections were hybridized with RNA probe for 16 hr at 55 C. Slides were washed and treated with the anti-DIG polyclonal antibodies and then incubated with biotin conjugated anti-sheep IgG antibodies (Chemicon) in PBS for 1 hr. After washing, samples were reacted with the HRP-conjugated streptavidin (PerkinElmer) and signals were visualized by incubating the samples with TSA-Cy3 (Perkin Elmer). After ISH, slides were incubated with chicken anti-EFGP (Aves) (1:500) for overnight and visualized with Alexa-fluor conjugated secondary antibodies (Invitrogen).
Lentivirus Packaging
Lentivirus was generated as described previously (Auer et al., 2010.) In brief, 293TN cells were co-transfected with the expression vector plasmid (pSico-Crhbp-shRNA), together with packaging and envelope plasmids, using PEI solution (Polysciences INC #24765-2). Two days after transfection, viral particles were harvested and the supernatant was concentrated by ultracentrifugation. shRNA Design The Cre regulated conditional RNA interference plasmid, pSico was purchased from addgene (#11578). The 19-nt sequence (GAGC CATTCGAGCTAGAAA) used for knockdown of Crhbp mRNA was generated by pSicoOligomaker and the knock down efficiency was validated by western blotting. The sense oligo and antisense oligo containing Crhbp shRNA generated by pSicoOligomaker were digested by SacII and NotI after annealing and cloned into the pSico vector (Ventura et al., 2004) .
Western Blot
To test the knockdown efficiency of the shRNA crhbp, 293TN cells were co-transfected with pSico-crhbp-shRNA and pCMV-crhbpMyc (MR204660, ORIGENE) and a cre-expressing vector. Cell lysates were collected 48 hr after transfection. Protein extracts were loaded in 4%-12% Bis-Tris gel, transferred to PDVF membrane for analysis and immunobloted with anti-CRHBP primary antibodies (1:500, sc-20630, Santa Cruz) and anti-b actin (1:2000).
Real Time PCR Tissues were dissected from the mPFC and PVH of male and female wild-type mice. Total RNA was homogenized and isolated by RNAeasy Mini Kit (QIAGEN). The first strand cDNA was synthesized by SuperScript IV reverse transcriptase (Invitrogen). Quantitative real-time PCR was performed using 480 SYBR Green I Master in a LightCycler 480II system (Roche). Quantification was analyzed by the delta Ct method with Gapdh as an endogenous control. Brain samples of same age male and female mice were collected in the same day and processing of the samples was performed in parallel.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, precision measures (mean ± SEM) and statistical significance are reported in the Figures and the Figure Legends . Data are judged to be statistically significant when p < 0.05 by two tailed Mann Whitney test, One-way ANOVA or Two-way ANOVA. In figures, asterisks denote statistical significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001) as compared to controls. Pearson correlation coefficients were calculated with PRISM and statistical significance is based upon the assumption that values exhibit a Gaussian distribution. Statistical analysis was performed in Graph Pad PRISM 6. Tables S1 and S2 .
DATA AND SOFTWARE AVAILABILITY
Data Resources
ADDITIONAL RESOURCES
All TRAP-seq data were subjected to the work flow described in https://gensat.rockefeller.edu/heintzp30/Bioinformatics_Flow_ Chart.jsp 
